Flamma Enters Cooperative Agreement with Seven Star Pharmaceutical Services to Expand Solid State Services
Chignolo D’Isola, Bergamo, Italy – August 15, 2024 – The Flamma Group (“Flamma”), a global, fully integrated company producing and commercializing small molecule Active Pharmaceutical Ingredients (APIs) for the life science industry as well as a preeminent Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late stage intermediates for the Innovator Companies, announced a cooperative agreement with Seven Star Pharmaceutical Services (SS) to expand its solid state science services.
This collaboration will allow Flamma to service customers more effectively by identifying the proper version of their API. By looking at a variety of areas such as salt & co-crystal selection, crystallization development, polymorph investigation, and pre-formulation evaluation, this partnership will look to solve typical problematic areas in the development of new drugs.
Gianmarco Negrisoli, President Flamma USA, commented “We have been working with Seven Star for several years and felt that it was time to formalize our collaboration. The proximity to Flamma USA coupled with the expertise in house at Seven Star will be beneficial to existing and new customers. Solving crystallization issues early on can speed development and scale up which, in turn, is beneficial to all parties involved.”
“Working with the Flamma USA team has been rewarding. Our ability to turn projects around quickly has helped their customers succeed in their attempts to get their molecule into the clinical. We are very proud to be part of the process to bring new drugs forward,” says Sathyanarayana ‘Reddy’ Perumalla, Ph.D., Founder and Director, Seven Star Pharmaceutical Services. Flamma USA offers customers an easy entry point into the Flamma Group. Specializing on early stage & pre-clinical development of new drugs, the Malvern, PA facility can leverage Flamma Italy and Flamma Honkai to provide multiple options for securing ones supply chain.
Download press release here
